key: cord-0894334-mujiye6l authors: Zayet, Souheil; Gendrin, Vincent; Royer, Pierre‐Yves; Toko, Lynda; Kadiane‐Oussou, N'dri Juliette; Klopfenstein, Timothée title: Comparison of COVID‐19 and influenza in adult patients: Neurological symptoms input date: 2020-12-17 journal: J Med Virol DOI: 10.1002/jmv.26710 sha: 7644bd3b3995337ae8c615657019c7999aa017c8 doc_id: 894334 cord_uid: mujiye6l We have read with interest the article of Zhang et al. entitled 'Differentiation of COVID-19 from seasonal influenza: A multicenter comparative study' 1 which compare the clinical features and outcomes of hospitalized COVID-19 patients (n=211) with influenza patients (n=115). This article is protected by copyright. All rights reserved. To the Editor, We have read with interest the article of Zhang et al. 1 entitled "Differentiation of COVID-19 from seasonal influenza: A multicenter comparative study" which compare the clinical features and outcomes of hospitalized coronavirus disease 2019 (COVID-19) patients (n = 211) with influenza patients (n = 115). Patients with influenza exhibited higher proportions of cough, expectoration, chest pain, dyspnea, and vomiting than patients with COVID-19 (p < .05). Compared to patients with COVID-19, hospitalized influenza patients were older and the incidence rates of comorbidities including cardiovascular diseases (hypertension and coronary heart disease) were significantly higher. In contrast, comorbidities such as bronchitis and immunocompromised conditions were significantly more common in COVID-19 compared to influenza patients. In this study, patients with influenza developed mild-to-moderate symptoms upon hospital admission, but none of the severe or fatal cases was recorded. By contrast, more than a fifth of patients in the COVID-19 cohort was later transferred to the intensive care unit (ICU). We have recently published a retrospective and observational study in Nord Franche-Comté Hospital comparing clinical features and outcomes of mild-to-moderate forms of COVID-19 and seasonal influenza 2 . Between February 26th and March 14th, 2020, we enrolled 124 adult patients (≥18 years) with confirmed COVID-19 (n = 70) or confirmed influenza (n = 54) who consulted (n = 59/124) or were hospitalized (n = 65/124) in our hospital. Comparing the article of Zhang et al., 1 In our study, no significant differences were found in age, sex, and the different comorbidities between the two groups (Table 1) In contrast to the study of Zhang et al., 1 there were no statistical differences about in-hospital mortality between patients with influenza or COVID-19 which was lower than 10% in both cases (p = 1). There was also no significant difference in the evolution of the two diseases (duration of hospitalization, oxygen therapy requirement, and invasive mechanical ventilation). To conclude, we describe similar results as reported by Zhang et al. 1 about the comparison between COVID-19 and influenza, especially about clinical features. However, no significant differences were found between comorbidities and the outcome. Actually, most reports so far put the new loss of taste or smell to neurological symptoms instead of rhinolaryngological symptoms. 3 We have noticed that neurological symptoms are clearly more noticeable in COVID-19, especially anosmia, which is also described in another French study. 2, 4 Unfortunately, in the review of Zhang et al., 1 the authors did not emphasize the differences and similarities between the two viruses regarding neurological signs. This can help clinicians when dealing with cases of influenza-like illnesses during the period of co-circulation of influenza and severe acute respiratory syndrome coronavirus 2. The authors would like to thank all patients involved in the study and especially Dr. Hajer Zahra for her help. The data that support the findings of this study are available from the corresponding author upon reasonable request. Due to the retrospective nature of the study, the Ethics Committee of Nord Franche-Comté Hospital determined that patient consent was not required. The authors make sure to keep patient data confidential and compliance with the Declaration of Helsinki. T A B L E 1 Characteristics, clinical symptoms, and outcomes with COVID-19 or seasonal influenza SARS-CoV-2 (n = 70) Influenza (n = 54) p Age ( Differentiation of COVID-19 from seasonal influenza: a multicenter comparative study Clinical features of COVID-19 and influenza: a comparative study on Nord Franche-Comte cluster New loss of smell and taste: uncommon symptoms in COVID-19 patients in Medical features of COVID-19 and influenza infection: a comparative study Duration of hospitalization (days) (mean, extremes, SD) Days from conventional hospitalization to ICU (mean, extremes, SD) Duration of hospitalization in ICU (mean, extremes, SD) Note: Bold values indicate p < .05. Abbreviations: 95% CI COPD, chronic obstructive pulmonary disease COVID-19, coronavirus disease IMV, invasive mechanical ventilation; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. a Defined by: Cardiac failure, cardiac arrhythmia, coronary heart disease, stroke, peripheral arterial obstructive disease, and thromboembolic disease. b Defined by: Transplantation, cirrhosis, long-term steroids therapy, immunomodulators treatments, and human immunodeficiency virus The authors declare that there are no conflict of interests.